Imagion gains FDA clearance for HER2 breast cancer trial

The FDA has issued a Study May Proceed Notice for Imagion Biosystems’ Investigational New Drug application. ... Read More The post Imagion gains FDA clearance for HER2 breast cancer trial appeared first on Stockhead .

Go to News Site